896466-71-0

Basic information

• Product Name: 4-[[(1,1-diMethylethoxy)carbonyl]aMino]-1H-pyrazole-3-carboxylic acid
• Synonyms: 4-[[(1,1-diMethylethoxy)c...;4-{[(tert-butoxy)carbonyl]amino}-1H-pyrazole-3-carboxylic acid;4-[[(1,1-diMethylethoxy)carbonyl]aMino]-1H-pyrazole-3-carboxylic acid
• CAS NO: 896466-71-0
• Molecular Formula: C₉H₁₃N₃O₄
• Molecular Weight: 227.21722
• Mol File: 896466-71-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-[[(1,1-diMethylethoxy)carbonyl]aMino]-1H-pyrazole-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[[(1,1-diMethylethoxy)carbonyl]aMino]-1H-pyrazole-3-carboxylic acid(896466-71-0)
• EPA Substance Registry System: 4-[[(1,1-diMethylethoxy)carbonyl]aMino]-1H-pyrazole-3-carboxylic acid(896466-71-0)

Safety Data

• Hazardous Substances Data: 896466-71-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
DECPA is used as a therapeutic agent for the treatment of various medical conditions, including cancer and inflammation. Its unique chemical structure and properties make it a promising candidate for drug development, offering potential benefits in the management of these conditions.
Used in Cancer Treatment:
In the field of oncology, DECPA is used as an anticancer agent, targeting various types of cancer cells. Its mechanism of action may involve the modulation of cellular signaling pathways, leading to the inhibition of tumor growth and progression. Additionally, DECPA may demonstrate synergistic effects when combined with conventional chemotherapeutic drugs, enhancing their efficacy and overcoming drug resistance in cancer treatment.
Used in Inflammation Management:
DECPA is also used in the management of inflammatory conditions, leveraging its potential to modulate inflammatory pathways and reduce the associated symptoms. This application may contribute to the development of novel anti-inflammatory drugs, offering alternative treatment options for patients suffering from various inflammatory disorders.
Used in Drug Delivery Systems:
To enhance the therapeutic potential of DECPA, researchers are exploring the development of drug delivery systems that can improve its bioavailability, delivery, and overall efficacy. These systems may involve the use of organic or metallic nanoparticles as carriers, facilitating targeted delivery to specific cells or tissues and optimizing the therapeutic outcomes of DECPA in various medical applications.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 360056-45-7 methyl 4-amino-1H-pyrazole-3-carboxylate 
• 122-42-9 carbamic acid, phenyl-, 1-methylethyl ester 

Downstream Products

• 896466-72-1 [3-(2-amino-4-morpholin-4-ylmethyl-phenylcarbamoyl)-1H-pyrazol-4-yl]-carbamic acid tert-butyl ester 

Relevant articles and documents

PHARMACEUTICAL COMBINATIONS OF 1-CYCLOPROPYL-3- [3-(5-M0RPHOOLIN-4-YL-METHYL-1H-BENZOIMIDAZOL-2-YL)- LH-1-PYRAZOL-4-YL]- UREA

The invention provides combinations of an ancillary compound and a compound which is a salt of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea selected from the lactate and citrate salts and mixtures thereof. Also p

PHARMACEUTICAL COMBINATIONS

The invention provides combinations of an ancillary compound of the formula (0): and a compound of the formula (I'): Also provided are crystalline forms of the constituent compounds, methods for making them and their uses in treating cancers.

PHARMACEUTICAL COMPOUNDS

The use of a compound for the manufacture of a medicament for the prophylaxis or treatment of: A. a disease state or condition mediated by a kinase which is BCR-abl, VEGFR, PDGFR, EGFR, Flt3, JAK (e.g. JAK2 or JAK3), C-abl, PDKl , Chk (e.g. Cbkl or Chk2),

PYRAZOLE COMPOUNDS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES

The invention provides a compound of the formula (I): or a salt, solvate, tautomer or N-oxide thereof, wherein M is selected from a group D1 and a group D2: and R', E, A and X are as defined in the claims. Also provided are pharmaceutical compositions con